您的位置: 首页 > 2024年9月 第55卷 第9期 > 文字全文
2023年7月 第38卷 第7期11
目录

microRNA-29b对子宫内膜癌细胞增殖、迁移和侵袭的影响

Effect of microRNA-29b on proliferation,migration and invasion of endometrial cancer cells

来源期刊: 广州医药 | 1002-1008 发布时间:2024-10-22 收稿时间:2025/11/13 18:45:17 阅读量:41
作者:
关键词:
子宫内膜癌微RNA增殖迁移侵袭
endometrial cancermicroRNAproliferationmigrationinvasion
DOI:
10.3969/j.issn.1000-8535.2024.09.006
收稿时间:
2024-01-24 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨微RNA-29b(miR-29b)对子宫内膜癌细胞增殖、迁移和侵袭的影响。方法 子宫内膜癌HEC-1-B细胞分为miR-29b模拟物组(MM组)、miR-29b阻遏物组(MR组)和阴性对照物组(MNC组),分别转染miR-29b拟似物、miR-29b阻遏物和miR-29b阴性对照物,每组设置6个复孔。以实时定量逆转录PCR检测miR-29b表达,以水溶性四氮唑(WST-1)检测miR-29b对HEC-1-B子宫内膜癌细胞增殖的影响,以Transwell小室检测HEC-1-B子宫内膜癌细胞迁移和侵袭的影响,以Western blot法检测磷酸酶张力蛋白同源物(PTEN)-蛋白激酶 B(AKT)通路蛋白表达水平。结果 MNC组、MM组、MR组miR-29b相对表达量分别为(2 032.1±873.4)、(19 272.8±2 087.9)、(472.7±105.6),组间比较差异有统计学意义(P<0.05)。MM组0、3、5、7 d时OD值分别为(0.32±0.06)、(0.53±0.08)、(1.13±0.12)和(1.92±0.14),MNC组0、3、5、7 d时OD值分别为(0.34±0.09)、(0.71±0.08)、(1.67±0.21)和(3.49±0.24),MR组0、3、5、7 d时OD值分别为(0.38±0.09)、(0.84±0.18)、(2.43±0.24)和(5.67±0.15),3组0 d时OD值比较差异无统计学意义(P=0.216),三组3 d、5 d、7 d时OD值比较差异存在统计学意义(P<0.001)。MNC组、MM组和MR组迁移细胞数分别为(403.9±23.8)(102.6±15.7)和(685.7±46.8)个,上述3组侵袭细胞数分别为(82.1±12.7)(38.2±10.6)和(124.6±21.6)个,MM组和MNC组上述指标比较差异均有统计学意义(P<0.05),MR组和MM组上述指标比较差异均有统计学意义(P<0.05)。MNC组、MM组、MR组PTEN蛋白相对表达量分别为(0.25±0.08)、(0.69±0.11)、(0.11±0.05),上述3组p-AKT蛋白相对表达量分别为(0.58±0.10)、(0.13±0.06)和(0.79±0.08),上述3组AKT蛋白相对表达量分别为(0.38±0.09)、(0.37±0.11)和(0.37±0.08),MM组与MNC组PTEN、p-AKT水平比较差异有统计学意义(P<0.05),AKT水平比较差异无统计学意义(P>0.05);MR组与MNC组、MM组PTEN、p-AKT水平比较差异有统计学意义(P<0.05),AKT水平比较差异无统计学意义(P>0.05)。结论 过表达miR-29b对子宫内膜癌细胞增殖、迁移和侵袭具有抑制作用,靶向PTEN-AKT可能是其重要作用途径。
Objective To investigate the effects of microRNA-29b on proliferation,migration and invasion of endometrial cancer cells.Methods The endometrial cancer HEC-1-B cells were divided into micro29b mimetic group(MM group),micro29b repressor group(MR group)and negative control group(MNC group),and the micro29b mimetic,micro29b repressor and micro29b negative control were transfected into each group,six compound holes with each group.The real-time quantitative reverse transcription polymerase chain reaction(RT-PCR)was used to detect the expression of mi29b,WST-1 was used to detect the effect of mi29b on the proliferation of HEC-1-B endometrial cancer cells,Transwell chamber was used to detect the migration and invasion of HEC-1-B endometrial cancer cells,and Western blot was used to detect the expression level of PTEN-AKT pathway protein.Results The relative expression levels of microRNA-29b in MNC group,MM group and MR group were(2 032.1±873.4),(19 272.8±2 087.9)and(472.7±105.6),respectively,and there were significant differences between groups(P<0.05).OD values of MM group at 0 d,3 d,5 d and 7 d were(0.32±0.06),(0.53±0.08),(1.13±0.12)and(1.92±0.14)respectively.The OD values of MNC group at 0,3,5 and 7 days were(0.34±0.09),(0.71±0.08),(1.67±0.21)and(3.49±0.24)respectively.The OD values of MR group at 0 d,3 d,5 d and 7 d were(0.38±0.09),(0.84±0.18),(2.43±0.24)and(5.67±0.15)respectively.There was no significant difference in OD value between the three groups on day 0 (P=0.216).There were significant differences in OD value between the three groups on day 3,day 5 and day 7(P<0.001).The number of migrating cells in MNC group,MM group and MR group were(403.9±23.8)cells,(102.6±15.7)cells and(685.7±46.8)cells,respectively.The number of invasive cells in the above three groups were(82.1±12.7)cells,(38.2±10.6)cells and(124.6±21.6)cells.There were significant differences in the above indexes between MM group and MNC group(P<0.05),also between MR group and MM group(P<0.05).The relative expression levels of PTEN protein in MNC group,MM group and MR group were(0.25±0.08),(0.69±0.11)and(0.11±0.05).The relative expression levels of p-AKT protein in the above three groups were(0.58±0.10),(0.13±0.06)and(0.79±0.08).The relative expression levels of AKT protein in the above three groups were(0.38±0.09),(0.37±0.11)and(0.37±0.08),respectively.Compared with MNC group,the levels of PTEN and p-AKT in MM group had statistical significance(P<0.05),but there was no statistical difference in AKT level(P>0.05).Compared with MNC group and MM group,the levels of PTEN and p-AKT in MR group had statistical significance(P<0.05),and there was no statistical difference in AKT level(P>0.05).Conclusions Overexpression of microRNA-29b can inhibit the proliferation,migration and invasion of endometrial cancer cells,and targeting PTEN-AKT may be an important pathway.
1、 WU Y,WANG J,GE L N,et al.Significance of a PTEN mutational status-associated gene signature in the progression and prognosis of endometrial carcinoma[J].Oxid Med Cell Longev,2022(2022):5130648. WU Y,WANG J,GE L N,et al.Significance of a PTEN mutational status-associated gene signature in the progression and prognosis of endometrial carcinoma[J].Oxid Med Cell Longev,2022(2022):5130648.
2、 PEREVALOVA A M,KOBELEV V S,SISAKYAN V G,et al.Role of tumor suppressor PTEN and its regulation in malignant transformation of endometrium[J].Biochemistry(Mosc),2022 ,87(11):1310-1326. PEREVALOVA A M,KOBELEV V S,SISAKYAN V G,et al.Role of tumor suppressor PTEN and its regulation in malignant transformation of endometrium[J].Biochemistry(Mosc),2022 ,87(11):1310-1326.
3、 CERAMI E,GAO J,DOGRUSOZ U,et al.The cBio cancer genomics portal:An open platform for exploring multidimensional cancer genomics data[J].Cancer Discov,2012,2(5):401-404. CERAMI E,GAO J,DOGRUSOZ U,et al.The cBio cancer genomics portal:An open platform for exploring multidimensional cancer genomics data[J].Cancer Discov,2012,2(5):401-404.
4、 WANG Y,ZHANG T,H E X.Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer[J].Front Oncol,2023(13):1279822. WANG Y,ZHANG T,H E X.Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer[J].Front Oncol,2023(13):1279822.
5、 WANG H Y,GUAN X Y,TU Y S,et al.MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN[J].J Exp Clin Cancer Res,2015,34(1):59. WANG H Y,GUAN X Y,TU Y S,et al.MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN[J].J Exp Clin Cancer Res,2015,34(1):59.
6、 ZHANG W Y,WU Q W,LI U Y,et al.LncRNA HOTAIR promotes chemoresistance by facilitating epithelial to mesenchymal transition through miR-29b/PTEN/PI3K signaling in cervical cancer[J].Cells Tissues Organs,2022,211(1):16-29. ZHANG W Y,WU Q W,LI U Y,et al.LncRNA HOTAIR promotes chemoresistance by facilitating epithelial to mesenchymal transition through miR-29b/PTEN/PI3K signaling in cervical cancer[J].Cells Tissues Organs,2022,211(1):16-29.
7、 JIA L F,HUANG Y P,ZHENG Y F,et al.MiR-29b suppresses proliferation,migration,and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1[J].Oral Oncol,2014,50(11):1062-1071. JIA L F,HUANG Y P,ZHENG Y F,et al.MiR-29b suppresses proliferation,migration,and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1[J].Oral Oncol,2014,50(11):1062-1071.
8、 MILLER K A,DEGAN S,WANG Y,et al.PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression[J].Oncogene,2024,43(1):22-34. MILLER K A,DEGAN S,WANG Y,et al.PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression[J].Oncogene,2024,43(1):22-34.
9、 YU L,WEI J,LIU P.Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J].Semin Cancer Biol,2022(85):69-94. YU L,WEI J,LIU P.Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J].Semin Cancer Biol,2022(85):69-94.
10、 HE Y,SUN M M,ZHANG G G,et al.Targeting PI3K/Akt signal transduction for cancer therapy[J].Signal Transduct Target Ther,2021,6(1):425. HE Y,SUN M M,ZHANG G G,et al.Targeting PI3K/Akt signal transduction for cancer therapy[J].Signal Transduct Target Ther,2021,6(1):425.
11、 BLOOMFIELD J,SABBAH M,CASTELA M,et al.Clinical value and molecular function of circulating microRNAs in endometrial cancer regulation:A systematic review[J].Cells, 2022,11(11):1836. BLOOMFIELD J,SABBAH M,CASTELA M,et al.Clinical value and molecular function of circulating microRNAs in endometrial cancer regulation:A systematic review[J].Cells, 2022,11(11):1836.
12、 DONKERS H,BEKKERS R,GALAAL K.Diagnostic value of microRNA panel in endometrial cancer:A systematic review[J].Oncotarget,2020,11(21):2010-2023. DONKERS H,BEKKERS R,GALAAL K.Diagnostic value of microRNA panel in endometrial cancer:A systematic review[J].Oncotarget,2020,11(21):2010-2023.
13、 HUTT S,TAILOR A,ELLIS P,et al.The role of biomarkers in endometrial cancer and hyperplasia:A literature review[J].Acta Oncol,2019,58(3):342-352. HUTT S,TAILOR A,ELLIS P,et al.The role of biomarkers in endometrial cancer and hyperplasia:A literature review[J].Acta Oncol,2019,58(3):342-352.
14、 ZHAO J F,MA X Y,XU H Q.miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis[J].Oncol Lett,2022,24(2):289. ZHAO J F,MA X Y,XU H Q.miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis[J].Oncol Lett,2022,24(2):289.
15、 ZOU S H,CHEN F,ZHANG L Q,et al.The diagnostic value of circulating miR-29 family for digestive system malignancies:A meta-analysis[J].Lab Med,2024,55(1):1-7. ZOU S H,CHEN F,ZHANG L Q,et al.The diagnostic value of circulating miR-29 family for digestive system malignancies:A meta-analysis[J].Lab Med,2024,55(1):1-7.
16、 李璟蓉,思远,赵瑞,等.microRNA-29a-3p 对白介素-22诱导的HaCaT细胞增殖的影响研究[J].广州医药,2020,51(3):26-30. 李璟蓉,思远,赵瑞,等.microRNA-29a-3p 对白介素-22诱导的HaCaT细胞增殖的影响研究[J].广州医药,2020,51(3):26-30.
17、 刘志梅,白洁,吴少群.微小RNA-29b 对卵巢癌细胞生长的抑制作用机制研究[J].中国临床药理学杂志,2021,37(9):1066-1069. 刘志梅,白洁,吴少群.微小RNA-29b 对卵巢癌细胞生长的抑制作用机制研究[J].中国临床药理学杂志,2021,37(9):1066-1069.
18、 唐金舟,毛爱红,廖世奇.miRNA-29b在癌症发生发展中的作用机制及其临床应用的研究进展[J].中国肿瘤生物治疗杂志,2019,26(12):1410-1416. 唐金舟,毛爱红,廖世奇.miRNA-29b在癌症发生发展中的作用机制及其临床应用的研究进展[J].中国肿瘤生物治疗杂志,2019,26(12):1410-1416.
19、 LENG Y,CHEN Z X,DING H,et al.Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis[J].Cancer Cell Int,2021,21(1):17. LENG Y,CHEN Z X,DING H,et al.Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis[J].Cancer Cell Int,2021,21(1):17.
20、 WANG L H,HUANG J,WU C R,et al.Downregulation of miR-29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer[J].Mol Med Rep,2023,28(3):162. WANG L H,HUANG J,WU C R,et al.Downregulation of miR-29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer[J].Mol Med Rep,2023,28(3):162.
21、 XU M,TIAN G L,HAO C C,et al.MicroRNA-29 targets FGF2 and inhibits the proliferation,migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(13):7199. XU M,TIAN G L,HAO C C,et al.MicroRNA-29 targets FGF2 and inhibits the proliferation,migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(13):7199.
22、 HUSSEN B M,HIDAYAT H J,SALIHI A,et al.MicroRNA:A signature for cancer progression[J].Biomed Pharmacother,2021(138):111528. HUSSEN B M,HIDAYAT H J,SALIHI A,et al.MicroRNA:A signature for cancer progression[J].Biomed Pharmacother,2021(138):111528.
23、 MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021 ,7(1):88. MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021 ,7(1):88.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录